Article info

PDF

Extended report
Evaluation of abatacept administered subcutaneously in adults with active rheumatoid arthritis: impact of withdrawal and reintroduction on immunogenicity, efficacy and safety (phase Iiib ALLOW study)
  1. Correspondence to Dr Jeffrey Kaine, Sarasota Arthritis Research Center, 1945 Versailles Street #101, Sarasota, FL 34239, USA; jkainemd{at}gmail.com
View Full Text

Citation

Kaine J, Gladstein G, Strusberg I, et al
Evaluation of abatacept administered subcutaneously in adults with active rheumatoid arthritis: impact of withdrawal and reintroduction on immunogenicity, efficacy and safety (phase Iiib ALLOW study)

Publication history

  • Accepted August 11, 2011
  • First published September 13, 2011.
Online issue publication 
November 30, 2011

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.